ATC codes:
L01AA01
EMLc
Indication
Rhabdomyosarcoma primary site
ICD11 code:
2C25.Z
INN
Cyclophosphamide
Medicine type
Chemical agent
List type
Complementary
(EML)
(EMLc)
(EMLc)
Formulations
Parenteral > General injections > IV:
500 mg in vial powder for injection ;
1 g in vial powder for injection ;
2 g in vial powder for injection
Oral > Solid > dosage form: 25 mg ; 50 mg
Oral > Solid > dosage form: 25 mg ; 50 mg
EML status history
Sex
All
Age
Also recommended for children
Therapeutic alternatives
The recommendation is for this specific medicine
Patent information
Patents have expired in most jurisdictions
Read more
about patents.
Summary of evidence and Expert Committee recommendations
Following the review of the age-appropriateness of formulations on the EMLc, the Expert Committee recommended the listings for oral dosage forms of cyclophosphamide on the EML and EMLc be amended to replace 'tablet' with 'solid oral dosage form' to reflect the availability also of capsules and allow greater flexibility in procurement.